<?xml version="1.0" ?>
<tei xml:space="preserve">
	<teiHeader>
		<fileDesc xml:id="_995D6B3C63471E9DE5E17D95A304C542181752B9"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<docTitle>
	<titlePart>THREE-DIMENSIONAL COMPUTER-ASSISTED ANALYSIS OF<lb/> SECTOR BIOPSY OF THE PROSTATE<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>PIERRE I. KARAKIEWICZ, JAMES A. HANLEY, AND MICHEL BAZINET<lb/></docAuthor>
	</byline>

	ABSTRACT<lb/>
	<div type="abstract">Objectives. To assess the relationship between tumor volume, gland volume, number of sectors submitted<lb/> to biopsy, and prostatic biopsy detection rate.<lb/> Methods. Using a three-dimensional mathematical model of the prostate, we assessed detection rates<lb/> achieved with 4-, 6-, 8-, 10-, and 12-sector biopsies for glands ranging from 20 to 100 cc and peripheral<lb/> zone tumors ranging from 0.3 to 1.4 cc.<lb/> Results. Quadrant and sextant biopsy approaches only yielded from 6.2% to 13.4% and 8.6% to 18.3%,<lb/> respectively, of lesions in a 40-cc gland. Conversely, 10-and 12-sector approaches yielded, respectively,<lb/> from 19.8% to 48.8% and 25.4% to 62% of lesions for the same gland size. When assessed according to the<lb/> density of sampling, one biopsy core used for every 1.5 to 3.5 cc of prostatic tissue detected 42.5% of 0.5-cc<lb/> lesions. For the same lesion size, the density of sampling per biopsy core was then decreased to intervals<lb/> extending from 3.6 to 7.5 cc, 7.6 to 12.5 cc, and 12.6 to 25 cc. These sampling density intervals yielded,<lb/> respectively, 25.0%, 15.8%, and 9.8% detection rates.<lb/> Conclusions. On the basis of our results, a gland volume-based biopsy algorithm is likely to result in<lb/> improved detection of clinically significant prostate cancer.</div>

	<reference>UROLOGY 52: 208-212, 1998.</reference>

	<note type="copyright">© 1998,<lb/> Elsevier Science Inc. All rights reserved.<lb/></note>

	<byline>
	<affiliation>From the Departments of Urology and Biostatistics, McGill<lb/> University,</affiliation>
	</byline>

	<address>Montreal, Quebec, Canada<lb/></address>

	Reprint requests:
	<byline>
	<docAuthor>Pierre I. Karakiewicz, M.D., ࡆ Armen G.<lb/> Aprikian, M.D.,</docAuthor>
	</byline>

	<byline>
	<affiliation>Department of Urology, Montreal General Hos-<lb/>pital,</affiliation>
	</byline>

	<address>Cedar Avenue 1650, Montreal, QC, Canada H3G 1A4<lb/></address>

	<note type="submission">Submitted: July 8, 1997, accepted (with revisions): March 3, 1998<lb/></note>

	ADULT UROLOGY<lb/>
	<note type="copyright">© 1998, ELSEVIER SCIENCE INC.<lb/></note>

	0090-4295/98/$19.00<lb/> 208 ALL RIGHTS RESERVED<lb/>
	<idno>PII S0090-4295(98)00175-7</idno>

		</front>
	</text>
</tei>
